Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Advances in Targeted Therapy of HER2-Negative Breast Cancer
Junsha An, Cheng Peng, Xiaofang Xie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17

Showing 17 citing articles:

Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study
Manar G. Salem, Dina M. Abu El-Maaty, Yassmina I. Mohey El-Deen, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4898-4898
Open Access | Times Cited: 40
Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer
Jingjun Sun, Haiyan Zhao, Weixuan Xu, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 31
PTT-Mediated Inhibition of Cancer Proliferation and Tumor Progression by DARPin-Coated Gold Nanoparticles
Г. М. Прошкина, Е. И. Шрамова, Ekaterina V. Serova, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 2-2
Open Access
Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review
Melinda-Ildiko Mitranovici, Laura Caravia, Liviu Moraru, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 277-277
Open Access
Targeting CD276 for T cell-based immunotherapy of breast cancer
Ilona Hagelstein, Laura Wessling, Alexander Rochwarger, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Jatrophone: a cytotoxic macrocylic diterpene targeting PI3K/AKT/NF-κB pathway, inducing apoptosis and autophagy in resistant breast cancer cells
Khawlah Shari, Rania A. El Gedaily, Rasha M. Allam, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Anticancer Studies of Newly Synthesized Thiazole Derivatives: Synthesis, Characterization, Biological Activity, and Molecular Docking
Fawziah A. Al‐Salmi, Abdulmohsen H Alrohaimi, Mohammed El Behery, et al.
Crystals (2023) Vol. 13, Iss. 11, pp. 1546-1546
Open Access | Times Cited: 6
Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer
Eman Fayad, Dalal Nasser Binjawhar, Abeer A. Ageeli, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 8, pp. 707-721
Closed Access | Times Cited: 1
Synthesis and antiproliferative potency of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one based new binary heterocyclic molecules: in vitro cell-based anticancer studies
Avik Maji, Ambati Himaja, Sripathi Nikhitha, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3057-3069
Closed Access | Times Cited: 1
An Introduction to Recent Approaches Underlying Mechanistic Insights Harboring Oncobiology
R. C. Sobti, Aastha Sobti
(2024), pp. 3-47
Closed Access | Times Cited: 1
Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions
Zanyar HajiEsmailPoor, Peyman Tabnak, Behnam Ahmadzadeh, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113507-113507
Open Access | Times Cited: 8
Oxygen tension-dependent variability in the cancer cell kinome impacts signaling pathways and response to targeted therapies
Adedeji K. Adebayo, Poornima Bhat-Nakshatri, Christopher Davis, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110068-110068
Open Access
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Fátima Cardoso, Kim M. Hirshfield, Kimberly A. Kraynyak, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access
Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy
Junsha An, Yajie Lu, Yuxi Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Nuclear expression of Ku70/80 is associated with CHEK2 germline mutations in breast cancer
Jakub Rosik, Machaj Filip, B. Daniel, et al.
Polish Journal of Pathology (2023) Vol. 74, Iss. 2, pp. 75-81
Open Access
An Introduction to Recent Approaches Underlying Mechanistic Insights Harboring Oncobiology
R. C. Sobti, Aastha Sobti
(2023), pp. 1-44
Closed Access
Based on Network Pharmacology and Molecular Docking for Research the Hedyotis Diffusa Mechanism on Breast Cancer
li Jun Zhang, Kuan Cao, Lei Deng, et al.
(2022) Vol. 1152, pp. 130-137
Closed Access
Page 1

Scroll to top